Valeant Pharmaceuticals OKs New $2 Billion Securities Repurchase Program

By Staff
Friday, November 21, 2014 12:26 AM LAVAL, Quebec— Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that its board of directors has authorized a new securities repurchase program (the "Securities Repurchase Program").

Actavis to Acquire Allergan to Create Top 10 Global Growth Pharma Company With $23 Billion in Revenue

By Staff
Monday, November 17, 2014 9:30 AM DUBLIN, Ireland and IRVINE, Calif.— Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) today announced that they have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock.

InSite Vision Reports Third Quarter 2014 Financial Results

By Staff
Wednesday, November 12, 2014 12:23 AM ALAMEDA, Calif.— InSite Vision Incorporated (OTCBB: INSV) reported financial results for the quarter ended Sept. 30, 2014. Revenues for the third quarter of 2014 were $0.4 million compared to $5.3 million for the same period in 2013.

New Look Eyewear Announces Results for Third Quarter 2014

By Staff
Monday, November 10, 2014 12:26 AM MONTREAL— New Look Eyewear Inc. (BCI) has announced its third quarter results for 2014, reporting revenues of $32.5 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $6.2 million for the third quarter ended Sept. 27, 2014.

Avegant Raises $9.37 Million in New Round of Funding

By Staff
Monday, November 10, 2014 12:23 AM REDWOOD CITY, Calif.— Avegant, a developer of wearable near eye displays based here, announced that they have raised $9.37 million in a Series A funding.

Safilo Reports Third Quarter and Year-to-Date 2014 Results

By Staff
Friday, November 07, 2014 12:26 AM PADUA, Italy—The Board of Directors of Safilo Group S.p.A. (SFLG.MI), has approved the results of the third quarter and first nine months of 2014, ended Sept. 30, 2014.

Spy Inc. Reports Q3 and First Nine Months Financial Results for 2014

By Staff
Friday, November 07, 2014 12:23 AM CARLSBAD, Calif.— SPY Inc. (OTCBB: XSPY) has announced the financial results for the third quarter and nine months ended Sept. 30, 2014.

Luxottica Reports Strong Retail and Wholesale Q3

By Staff
Friday, October 31, 2014 12:23 AM MILAN, Italy— Luxottica Group (NYSE: LUX) reported strong sales in its wholesale and retail sectors for the third fiscal quarter, ending Sept. 30.

Hoya Reports Strong Growth in Second Quarter

By Staff
Friday, October 31, 2014 12:20 AM TOKYO— Hoya Corp. (TOKYO: 7741) reported a significant upturn in revenue and profit for the second quarter ended Sept. 30, 2014. During the quarter, revenues totaled 121,242 million yen, increasing by 18.6 percent from the same period the previous year.

Luxottica Reports Strong Retail and Wholesale Q3, Officially Confirms Two Co-CEOS, Names New CFO

By Staff
Wednesday, October 29, 2014 4:05 PM MILAN—Against the backdrop of a strong third fiscal quarter, which saw increases in the company’s retail and wholesale division, worldwide, Luxottica Group said its board of directors, today, upon the chairman Leonardo Del Vecchio’s recent proposal, entrusted Massimo Vian, on an interim basis, with all executive responsibilities until Adil Mehboob-Khan joins Luxottica as co-CEO.

Novartis Reports Solid Sales Growth in 3Q 2014

By Staff
Wednesday, October 29, 2014 12:23 AM BASEL, Switzerland— Novartis (NVS: NYSE) delivered solid sales growth with strong margin expansion and major innovation in the third quarter ended Sept. 30, 2014.

Allergan Reports Historical Dollar Sales Gains for Q3

By Staff
Wednesday, October 29, 2014 12:14 AM IRVINE, Calif.—With net sales of $1,790.7 million for the third quarter ended Sept. 30, 2014, a 17.2 percent increase over net sales for the third quarter of 2013, Allergan, Inc. (NYSE: AGN) reported its “strongest increase in absolute dollar sales in any quarter in our history,” according to David E.I. Pyott, chairman and CEO, in a statement released by Allergan on Monday, Oct. 27, 2014.

Essilor 3Q ’14 Sales Up 14.5 Percent at Constant Exchange Rates

By Staff
Monday, October 27, 2014 12:23 AM CHARENTON-LE-PONT, France— Essilor International (Reuters: ESSI.PA) announced Friday that consolidated revenue for the third quarter of 2014, ending Sept. 30, climbed to €1,415 million, an increase of 14.5 percent, excluding the currency effect, over third quarter 2013.

Valeant Pharmaceuticals Reports Revenue Increase for Q3

By Staff
Wednesday, October 22, 2014 12:23 AM LAVAL, Quebec—Valeant Pharmaceuticals, Inc. (NYSE/TSX: VRX) reported its total revenue for the third fiscal quarter ended Sept. 30, 2014, was $2.1 billion, up 33 percent compared to the third quarter of 2014, with the U.S. and emerging market businesses contributing strong double-digit, same-store organic growth.

New Look Closes Purchase of Greiche & Scaff

By Staff
Wednesday, October 22, 2014 12:20 AM MONTREAL— New Look Eyewear Inc. ((TSX: BCI)), the Canadian optical retailer, completed its acquisition of certain optical assets and business forming part of Optic Direct Inc, carrying on business under the Greiche & Scaff banner in Quebec.
Loading...